SABCS 2022 Meeting News Preview - 1

December 6-10, 2022 | Henry B. Gonzalez Convention Center | San Antonio, Texas |
2022 Scheduleat-a-Glance
and collaborate
9 San Antonio
awaits #SABCS22
From basic science breakthroughs
to practice-changing new therapies,
SABCS 2022 covers the spectrum
of breast cancer research
ver the course of five
days in December, more
than 8,000 researchers,
clinicians, students, and patient
advocates from over 90 countries
will gather in San Antonio to learn
about the latest advances in the
biology, etiology, prevention, diagnosis,
and therapy of breast cancer
and premalignant breast disease.
You're going to want to be there,
too, so register today for this year's
San Antonio Breast Cancer Symposium,
December 6-10, at the Henry
B. Gonzalez Convention Center.
From plenary and award lectures
delivered by some of the top
thought-leaders and pioneers in
breast cancer research and care to
late-breaking and practice-changing
findings from some of the most
cutting-edge research being conducted
in the field, the SABCS 2022
Program Committee has outdone itself
in assembling a robust program
with something for everyone.
With dozens of educational
sessions, mini-symposia, forums,
workshops, case discussions, oral
abstract presentations, spotlight
discussions, and poster sessions,
SABCS 2022 has everything you've
come to expect from the world's
premier scientific symposium for
Early-Bird Discount Ends Soon - Register Today!
his year's SABCS once again offers attendees
the option to participate in person in San
Antonio or virtually from anywhere in the world.
All attendees will have access to the same
state-of-the-art symposium featuring five days
of expert lectures, groundbreaking research
presentations, case discussions, networking
opportunities, and more.
Special early-bird pricing is available for both
in-person and virtual registrations until October
31. Other discounts apply, with valid identification,
for residents or postdoctoral fellows, patient
advocates, students, AACR members, and UT
Health San Antonio faculty and staff.
researchers, health professionals,
and those with a special interest in
breast cancer. Register and book
your housing today!
After nearly 45 years on the cutting
edge of breast cancer research,
there's always something new at the
San Antonio Breast Cancer Symposium,
and this year is no exception.
Alongside the latest research findings
and the newest breast cancer
therapies, SABCS 2022 attendees
will find some interesting and engaging
new offerings in store for them.
Covering some of the most talked-about
topics in breast cancer
care, the SABCS 2022 program
includes two new " Controversies "
sessions that you will not want to
miss. The two new sessions-one
on clinical controversies and one
on translational controversies-
and will feature " lightning discussions "
between experts in the field
on topics that will help to improve
patient care.
Lisa Carey, MD, ScM, FASCO, of
the UNC-Lineberger Comprehensive
Cancer Center in Chapel Hill,
NC, will moderate the Clinical Controversies
session. Komal Jhaveri,
MD, FACP, of Memorial Sloan Kettering
Cancer Center in New York
City, NY, will moderate the Translational
Controversies session.
Clinical Controversies:
* To Clip or Not to Clip
Discussants: Abigail Caudle,
MD, of MD Anderson Cancer
Center in Houston, TX, and
Viviana E. Galimberti, MD,
MPH, of the European Institute
of Oncology in Milan, Italy.
* Duration of Endocrine Therapy
Discussants: Kathryn Ruddy,
MD, PhD, of the Mayo Clinic in
Rochester, MN, and Eleftherios
" Terry " Mamounas, MD, MSc,
of the Orlando Health Cancer
Institute, Orlando, FL.
* Post-neoadjuvant Therapy
Discussants: Heather
McArthur, MD, MPH, of UT
Southwestern in Dallas, TX
and Susan Domchek, MD, of
the University of Pennsylvania
School of Medicine in
Philadelphia, PA.
Translational Controversies:
Discussants: Hope S. Rugo,
MD, FASCO, of the University
of California San Francisco,
and Geoffrey Shapiro, MD,
PhD, of the Dana-Farber
Cancer Institute.
* Randomized Trials Versus
Real World Evidence
Discussants: Angela
DeMichele, MD, MSCE, of the
University of Pennsylvania in
Philadelphia, and Sean Khozin,
MD, MPH, of CancerLinQ, LLC
in New York City.
* Ki-67
Discussants: Nadia Harbeck,
MD, PhD, of LMU University
Hospital in Munich, and Torsten
Nielsen, MD, PhD, FRCPC,
of the University of British
Columbia in Vancouver, British
As part of SABCS's ongoing
commitment to health equity,
diversity, and inclusion, this year's
program includes an important
Special Session on Diversity to
be held on Tuesday, December 6.
Serving as co-chairs and panelists
for the session will be Thelma
Brown, BSc, University of Alabama
at Birmingham; Maimah Karmo,
BS, Tigerlily Foundation; Charles
Perou, PhD, University of North
Carolina at Chapel Hill; Patty
Spears, BS, University of North
Carolina at Chapel Hill. 
To receive the registration discount, please reserve
your hotel room with Orchid Events or SABCS
International Group Housing, the official SABCS
housing bureaus. Once you have received your
hotel acknowledgment number, please proceed to
registration. The hotel acknowledgement number
and hotel name must be entered when registering in
order to receive the registration discount. Book now
to get your preferred hotel. 

SABCS 2022 Meeting News Preview

Table of Contents for the Digital Edition of SABCS 2022 Meeting News Preview

SABCS 2022 Meeting News Preview - 1
SABCS 2022 Meeting News Preview - 2A
SABCS 2022 Meeting News Preview - 3
SABCS 2022 Meeting News Preview - 4
SABCS 2022 Meeting News Preview - 5
SABCS 2022 Meeting News Preview - 6
SABCS 2022 Meeting News Preview - 7A
SABCS 2022 Meeting News Preview - 8
SABCS 2022 Meeting News Preview - Insert-1
SABCS 2022 Meeting News Preview - Insert-2
SABCS 2022 Meeting News Preview - 9